-
1دورية أكاديمية
المؤلفون: Yanlin Li, Tongfei Wang, Yamin Zhang, Miao Li, Xiemin Feng, Rui Xu, Hong Xu, Weihu Xia, Yaning Zhao, Xinli Hou, Hui Wei, Zhiyan Liu, Ying Zan, Bing Zhao, Chunling Liu, Xiaopeng He, Xuan Liang, Mengjie Liu, Lili Jiang, Wenjuan Wang, Yuan Shen, Duolao Wang, Baibing Mi, Yixue Bai, Xin Yu, Xubo Huang, Xiaohui Jia, Xiaolan Fu, Hui Guo, Min Jiao
المصدر: Clinical and Translational Medicine, Vol 13, Iss 12, Pp n/a-n/a (2023)
مصطلحات موضوعية: Medicine (General), R5-920
وصف الملف: electronic resource
Relation: https://doaj.org/toc/2001-1326
-
2دورية أكاديمية
المؤلفون: Han Zheng, Wei Song, Xiemin Feng, Hong Zhao
المصدر: Frontiers in Oncology, Vol 11 (2021)
مصطلحات موضوعية: urachal carcinoma, serum marker, immunity therapy, targeted therapy, combination chemotherapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
3
المؤلفون: Xiemin Feng, Han Zheng, Hong Zhao, Wei Song
المصدر: Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncologyمصطلحات موضوعية: 0301 basic medicine, Oncology, immunity therapy, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Case Report, Targeted therapy, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Urachus, RC254-282, Chemotherapy, serum marker, combination chemotherapy, biology, business.industry, urachal carcinoma, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Combination chemotherapy, targeted therapy, Clinical trial, Regimen, 030104 developmental biology, medicine.anatomical_structure, 030220 oncology & carcinogenesis, FOLFIRI, biology.protein, Antibody, business
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::845e994e5724ef5e391f6aa1cd9ad672
https://www.frontiersin.org/articles/10.3389/fonc.2021.662589/full -
4
المؤلفون: Jie Cui, Tao Tian, Kejun Nan, Yun-Feng Hu, Ya-Huan Guo, Hong-Yi Zhang, Xiemin Feng, Jun-wei Ma
المصدر: Tumor Biology. 35:11701-11709
مصطلحات موضوعية: Programmed cell death, biology, business.industry, Autophagy, Cancer, Antineoplastic Agents, General Medicine, Pharmacology, medicine.disease, ErbB Receptors, Gefitinib, Neoplasms, Cancer cell, biology.protein, Animals, Humans, Medicine, Molecular Targeted Therapy, Erlotinib, Epidermal growth factor receptor, business, Protein Kinase Inhibitors, EGFR inhibitors, medicine.drug